JOSE HERNANDEZ: Open Payments
NPI 1912202938 · TOLUCA LAKE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 41 payments from 21 companies in 2025. Trend: 2023 $1,291 · 2024 $545 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Gilead Sciences, Inc. | 3 | $92 |
| Lundbeck LLC | 3 | $80 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $47 |
| Dexcom, Inc. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Alkermes, Inc. | 1 | $34 |
Products named: SUBLOCADE, REXULTI, TRELEGY ELLIPTA, RELISTOR, Kerendia, Ozempic, Dexcom G6 Transmitter, XIFAXAN.
Industry payments across CA — which companies pay providers there.
